Skip to main content


Gerd  Jomrich Gerd Jomrich

Department of Surgery (Division of General Surgery)
Position: Doctor-in-training

ORCID: 0000-0002-7294-4831
T +43 1 40400 56210

Further Information


Barrett Esophagus; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Fibroblast Growth Factors; Gastrectomy; Gastroesophageal Reflux; Neoadjuvant Therapy; Receptors, Fibroblast Growth Factor; Translational Medical Research

Research interests

  • Expression of Fibroblast Growth Factors and its Receptors in (neoadjuvant treated) Esophageal Cancer
  • Prognostic Value of preoeprative Laboratory Results in Esophageal Cancer
  • Biobanking: Establishing a Biobank for Upper-GI Malignancies

Techniques, methods & infrastructure

  • Upper-GI Biobank
  • Analyzing Esophageal Cancer RNASeq Data from TCGA (The Cancer Genome Atlas)
  • Immunohistochemistry (IHC)
  • Quantitative RT-PCR
  • Retrospective Clinical Studies

Selected publications

  1. Ahmed, M.A. et al., 2016. Fibroblast growth factor receptor 4 induced resistance to radiation therapy in colorectal cancer. Oncotarget. Available at:
  2. Kollmann, D. et al., 2017. Expression of Programmed Cell Death Protein 1 by Tumor-Infiltrating Lymphocytes and Tumor Cells is Associated with Advanced Tumor Stage in Patients with Esophageal Adenocarcinoma. Annals of Surgical Oncology. Available at:
  3. Jomrich, G. & Schoppmann, S., 2015. Targeting HER 2 and angiogenesis in gastric cancer. Expert Review of Anticancer Therapy, 16(1), pp.111-122. Available at:
  4. Jomrich, G. & Schoppmann, S.F., 2016. Targeted therapy in gastric cancer. European Surgery, 48(5), pp.278-284. Available at:
  5. Jomrich, G. et al., 2014. Stromal expression of carbonic anhydrase IX in esophageal cancer. Clinical and Translational Oncology, 16(11), pp.966-972. Available at: